Cart
sales@molnova.com
CDK8-IN-13
CAS No. 918523-75-8
CDK8-IN-13( —— )
Catalog No. M36400 CAS No. 918523-75-8
CDK8-IN-13 is a CDK8 inhibitor (IC50: 51.9 nM) with potent, selective and oral activity. CDK8-IN-13 induces apoptosis and reduces the expression of p-STAT1 S727 and p-STAT5 S726. CDK8-IN-13 exhibits anti-tumour activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 73 | In Stock |
|
| 5MG | 73 | In Stock |
|
| 10MG | 93 | In Stock |
|
| 25MG | 179 | In Stock |
|
| 50MG | 272 | In Stock |
|
| 100MG | 403 | In Stock |
|
| 200MG | 585 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCDK8-IN-13
-
NoteResearch use only, not for human use.
-
Brief DescriptionCDK8-IN-13 is a CDK8 inhibitor (IC50: 51.9 nM) with potent, selective and oral activity. CDK8-IN-13 induces apoptosis and reduces the expression of p-STAT1 S727 and p-STAT5 S726. CDK8-IN-13 exhibits anti-tumour activity.
-
DescriptionCDK8-IN-13 is a potent, selective and orally active CDK8 inhibitor with an IC50 value of 51.9 nM. CDK8-IN-13 induces Apoptosis. CDK8-IN-13 decreases the expression of p-STAT1 S727 and p-STAT5 S726. CDK8-IN-13 shows antitumor activity.
-
In VitroCell Proliferation AssayCell Line:molm-13, HL-60, MV4-11, MGC-803, MDA-MB-231, A375, A549 cells Concentration:0-50 μM Incubation Time:Result:Showed antiproliferative activity with GC50s of 1.57, 1.00, 4.61, >50, >50, >50, >50 μM, respectively.Western Blot Analysis Cell Line:HCT-116 cells Concentration:1, 2.5, 5, 10 μM Incubation Time:12 h Result:Decreased the expression of p-STAT1 S727 and p-STAT5 S726, andsuppressed the phosphorylation of STAT1 S727 induced by IFN-γ (10 ng/mL) in a dose-dependent manner.Apoptosis Analysis Cell Line:HL-60 cells Concentration:0, 1, 5, 10 μM Incubation Time:48 h Result:Induced approximately 7% and 36% apoptotic at concentrations of 5 and 10 μM, respectively.
-
In VivoAnimal Model:6-week-old Balb/C mice (C1498 cells)Dosage:40, 80 mg/kg Administration:P.o.; for 15 days Result:Decreased the tumor growth with no significant weight loss,the expression of Ki67 decreased in a dose-dependent manner, the level of phosphorylation of STAT1 S727 in tumor tissues was downregulated.
-
Synonyms——
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorApoptosis | CDK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number918523-75-8
-
Formula Weight237.26
-
Molecular FormulaC14H11N3O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (526.85 mM; Ultrasonic )
-
SMILESC(N)(=O)C=1C=C(C=2C=C3C(=NC2)NC=C3)C=CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
GSK854
GSK854 is a highly selective and potent inhibitor of troponin I interacting kinase (TNNI3K) that inhibits myocardial infarction-injured cellular pyroptosis and apoptosis in mice, which may limit oxidative stress, injury, and adverse remodeling in the ischemic heart.
-
Ecdysone
Ecdysone is a major steroid hormone in insects and herbs. Ecdysone triggers mineralocorticoid receptor activation and induces cellular apoptosis. Ecdysone signaling through Ecdysone receptor isoform B1 is required cell autonomously for the muscle death.
-
Bomedemstat ditosyla...
Bomedemstat ditosylate (IMG-7289 ditosylate) is an orally active lysine-specific demethylase 1 (LSD1) inhibitor with antitumor activity that potentiates the response to PD-1 inhibition in a homozygous model of SCLC, inhibits cancer cell proliferation, and induces apoptosis.
